0001192482-19-000534.txt : 20191216 0001192482-19-000534.hdr.sgml : 20191216 20191216164358 ACCESSION NUMBER: 0001192482-19-000534 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190927 FILED AS OF DATE: 20191216 DATE AS OF CHANGE: 20191216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Beck Kelly CENTRAL INDEX KEY: 0001791819 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36751 FILM NUMBER: 191287695 MAIL ADDRESS: STREET 1: 5 GREAT VALLEY PARKWAY, SUITE 160 CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ocugen, Inc. CENTRAL INDEX KEY: 0001372299 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 GREAT VALLEY PARKWAY STREET 2: SUITE 160 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 484-328-4698 MAIL ADDRESS: STREET 1: 5 GREAT VALLEY PARKWAY STREET 2: SUITE 160 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: HISTOGENICS CORP DATE OF NAME CHANGE: 20060810 3 1 edgar.xml PRIMARY DOCUMENT X0206 3 2019-09-27 0 0001372299 Ocugen, Inc. OCGN 0001791819 Beck Kelly C/O OCUGEN, INC. 5 GREAT VALLEY PARKWAY, SUITE 160 MALVERN, PA 19355 0 1 0 0 Vice President Stock Options (right to buy) 7.56 2019-09-27 2027-07-10 Common stock 14382 D Stock Options (right to buy) 7.56 2019-09-27 2027-12-15 Common Stock 11985 D Stock Options (right to buy) 13.52 2019-12-07 2028-12-07 Common Stock 9588 D 9,588 Stock Options became exercisable immediately, and the remaining 4,794 Warrants will become exercisable on July 9, 2020, subject to continued employment with Ocugen, Inc. (the "Company"). 3,995 Stock Options became exercisable immediately, and the remaining 7,990 Warrants will become exercisable 50% each on December 15, 2019 and December 14, 2020, subject to continued employment with the Company through the applicable vesting date. The Stock Options will become exercisable 1/3 each on December 7, 2019, December 7, 2020 and December 6, 2021, subject to continued employment with the Company through the applicable vesting date. /s/ Kelly Beck 2019-12-16 EX-24 2 beckpoa.htm POWER OF ATTORNEY

OCUGEN, INC.



POWER OF ATTORNEY



        Know all by these present, that I, the undersigned director and/or officer of Ocugen, Inc., a

Delaware corporation (the "Company"), hereby constitutes and appoints Shankar Musunuri, Sanjay

Subramanian, Kelly Beck and any Secretary or Assistant Secretary of the Company, and each of them, my

true and lawful attorneys-in-fact and agents, with full power to act, together or each without the other, with

full power of substitution and resubstitution, for me and in my name, place and stead, in any and all

capacities:



(i) to execute and file for and on behalf of the undersigned any reports on Forms 3, 4 and 5

(including any amendments thereto and any successors to such Forms) with respect to

ownership acquisition or disposition of securities of the Company that the undersigned may

be required to file with the U.S. Securities and Exchange Commission (the "SEC") in

accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the

"Exchange Act"), and the rules promulgated thereunder;



(ii) to execute and file for and on behalf of the undersigned any voluntary filings under Section

16(a) of the Exchange Act;



(iii) to request electronic filing codes from the SEC by filing the Form ID (including

amendments thereto) and any other documents necessary or appropriate to obtain codes and

passwords enabling the undersigned to file such reports electronically;



(iv) to prepare, file, and submit any documents or reports that may be required under SEC Rule

144 to permit the undersigned to sell Company common stock without registration under

the Securities Act of 1933, as amended (the "Securities Act") in reliance on Rule 144 as

amended from time to time; or



(v) take any other action of any type whatsoever in connection with the foregoing which, in the

opinion of such attorneys-in-fact, may be of benefit to, in the best interest of, or legally

required by, the undersigned, it being understood that the documents executed by such

attorneys-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in

such form and shall contain such terms and conditions as such attorneys-in-fact may

approve in such attorney-in-fact's or attorneys-in-fact's discretion.



             The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity

at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's

responsibilities to comply with Section 16(a) of the Exchange Act or the Securities Act.  The Company will

use all reasonable efforts to apprise the undersigned of applicable filing requirements for purposes of

Section 16(a) of the Exchange Act or the Securities Act.



            This Power of Attorney shall remain in full force and effect until the undersigned is no longer

required to file Forms 3, 4 and 5 with respect to the undersigned's holdings and transactions in securities

issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the

foregoing attorneys-in-fact.  This Power of Attorney revokes and replaces any prior Power of Attorney

executed by the undersigned with respect to the ownership, acquisition or disposition of securities of the

Company.



       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of

this 30th day of September, 2019.



 /s/ Kelly Beck

Name: Kelly Beck